News & Event
- Home
- News
- News & Event
Busan-si signed an MOU on investment worth KRW 50 bn with Daewoo Pharm
On June 23, Busan-si will sign a memorandum of understanding (MOU) with Daewoo Pharm, a bio-pharmaceutical company, to expand its ophthalmic drug manufacturing facility with an investment of around KRW 50 billion.
As part of the agreement, Daewoo Pharm will expand its state-of-the-art production base for ophthalmic drugs, including eye drops, on its vacant land at the company's headquarters in Saha District, Busan, by 2027.
With this investment, Daewoo Pharm plans to invest KRW 50 billion in the vacant land (with a total floor area of 6,403 square meters) at its headquarters and hire around 100 new employees.
Once the factory expansion is complete, the company expects to see an increase in its production capacity for its flagship ophthalmic eye drops, which will help resolve production challenges and establish a stable supply foundation.
Founded in Busan in 1976, Daewoo Pharm is a regional company that has steadily grown over the past 50 years. Based on its diverse expertise in manufacturing specialized pharmaceuticals and extensive experience, the company supplies products not only domestically but also internationally, with its sales showing a continuous upward trend.
osh9981@yna.co.kr
Source Text
** This article was translated from Korean.
Date
2025.06.24
Views
12
According to Yonhap News,
On June 23, Busan-si will sign a memorandum of understanding (MOU) with Daewoo Pharm, a bio-pharmaceutical company, to expand its ophthalmic drug manufacturing facility with an investment of around KRW 50 billion.
As part of the agreement, Daewoo Pharm will expand its state-of-the-art production base for ophthalmic drugs, including eye drops, on its vacant land at the company's headquarters in Saha District, Busan, by 2027.
With this investment, Daewoo Pharm plans to invest KRW 50 billion in the vacant land (with a total floor area of 6,403 square meters) at its headquarters and hire around 100 new employees.
Once the factory expansion is complete, the company expects to see an increase in its production capacity for its flagship ophthalmic eye drops, which will help resolve production challenges and establish a stable supply foundation.
Founded in Busan in 1976, Daewoo Pharm is a regional company that has steadily grown over the past 50 years. Based on its diverse expertise in manufacturing specialized pharmaceuticals and extensive experience, the company supplies products not only domestically but also internationally, with its sales showing a continuous upward trend.
osh9981@yna.co.kr
Source Text
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
Source: Yonhap News (June 23, 2024)
** This article was translated from Korean.